The role of adjuvant pharmacotherapy in the management of patients with a partial response to bariatric metabolic surgery-the first Australian experience
While adaptive circadian remodeling may preserve functional stability under changing biological conditions, pathological circadian misalignment is typically associated with disease states, accelerated aging, neurodegeneration, metabolic disorders, or chronic exposure to chronodisruptive factors such as irregular light exposure or feeding patterns ( Melatonin is not only the principal hormonal output of the circadian system but also a pleiotropic molecule with chronobiotic, antioxidant, immunomodulatory, and neuroprotective properties
Medicare coverage for weight loss drug semaglutide could cost up to $145B per year Medicares decision to cover semaglutide, the first weight loss drug approved by the U.S
Patients must reside in states where MEDVi operates and where services are legally available
Rather than pursuing unproven combinations of investigational and licensed agents, patients are encouraged to: Engage with NHS weight management services , which offer multidisciplinary support including dietary advice, behavioural therapy, and pharmacotherapy where appropriate including orlistat and, where eligible, GLP-1-based medicines Discuss licensed options with their GP if they meet eligibility criteria, including referral pathways for bariatric surgery in line with NICE obesity guidance Participate in clinical trials if interested in investigational agents such as retatrutide, through legitimate research pathways listed on the NIHR Clinical Research Network or ClinicalTrials.gov The safest and most effective treatments are those supported by robust clinical evidence, prescribed by qualified clinicians, and obtained through regulated supply chains